Literature DB >> 18285404

Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse.

Manon E Wildenberg1, Cornelia G van Helden-Meeuwsen, Joop P van de Merwe, Christophe Moreno, Hemmo A Drexhage, Marjan A Versnel.   

Abstract

Sjögren's syndrome is an autoimmune disease characterized by lymphocytic infiltration of the salivary glands. In the NOD mouse, a model for this disease, the development of lymphocytic infiltrates in the salivary glands is preceded by an accumulation of dendritic cells (DC). Given the key importance of DC in regulating the immune response, we characterized the DC isolated from NOD salivary glands. These DC lacked membrane expression of CCR5, whereas DC from control salivary glands did express this molecule. The lack of expression was present already prior to the onset of lymphocytic infiltration, indicating that this was not the result of ongoing inflammation. DC from other sources in the NOD mouse also showed a decrease in CCR5 expression. The lack of CCR5 expression in the NOD salivary gland was accompanied by an increase in inflammatory chemokines. Furthermore, DC from CCR5-/- animals or DC treated with a CCR5 antagonist showed increased secretion of IL-12. Interestingly, in Sjögren's syndrome patients, CCR5 expression on circulating monocytes was decreased and correlated to increased levels of IL-12. These data indicate that CCR5 has regulatory properties and that the lack of CCR5 in NOD DC contributes to the proinflammatory environment in the salivary glands.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285404     DOI: 10.1189/jlb.1107794

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

Review 1.  Contributions of Major Cell Populations to Sjögren's Syndrome.

Authors:  Richard Witas; Shivai Gupta; Cuong Q Nguyen
Journal:  J Clin Med       Date:  2020-09-22       Impact factor: 4.241

Review 2.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

3.  Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.

Authors:  Haijing Wu; Yi Lo; Albert Chan; Ka Sin Law; Mo Yin Mok
Journal:  Immunology       Date:  2016-09       Impact factor: 7.397

4.  Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Wayne B Dyer; Joanne C G Tan; Timothy Day; Lynette Kiers; Matthew C Kiernan; Con Yiannikas; Stephen Reddel; Karl Ng; Phillip Mondy; Peta M Dennington; Melinda M Dean; Halina M Trist; Cristobal Dos Remedios; P Mark Hogarth; Steve Vucic; David O Irving
Journal:  Brain Behav       Date:  2016-07-14       Impact factor: 2.708

5.  Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.

Authors:  Elena Carnero-Montoro; Marta E Alarcón-Riquelme; María Teruel; Guillermo Barturen; Manuel Martínez-Bueno; Olivia Castellini-Pérez; Miguel Barroso-Gil; Elena Povedano; Martin Kerick; Francesc Català-Moll; Zuzanna Makowska; Anne Buttgereit; Jacques-Olivier Pers; Concepción Marañón; Esteban Ballestar; Javier Martin
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.